Efficacy and Toxicity of Calcitonin Treatment in Children with Cherubism: A Single‐Center Cohort Study

Denosumab in pediatric bone disorders and the role of RANKL blockade: a narrative review

(2023) Daoxi Wang et al.   Translational Pediatrics

Denosumab Therapy in Cherubism

(2022) Steele I. Liles et al.   CLEFT PALATE-CRANIOFACIAL JOURNAL

Multiple versus solitary giant cell lesions of the jaw: Similar or distinct entities?

(2021) Willem H. Schreuder et al.   BONE

Dense sclerotic metaphyseal bands caused by denosumab therapy

(2020) Shane Dunnion et al.   PEDIATRIC RADIOLOGY

Cherubism: a systematic literature review of clinical and molecular aspects

(2020) B.R. Chrcanovic et al.   INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Positive Outcomes of Denosumab Treatment in 2 Patients With Cherubism

(2020) Eitan Bar Droma et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Efficacy and safety of denosumab treatment in a prepubertal patient with cherubism

(2020) Haruka Kawamura et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Adjuvant alendronic acid in the management of severe cherubism: a case report and literature review.

(2020) Daniel Bradley et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib

(2019) Pat Ricalde et al.   JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Pharmacological and surgical therapy for the central giant cell granuloma: A long-term retrospective cohort study

(2017) Willem Hans Schreuder et al.   JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY

Involution von Cherubismus im MRT unter Therapie mit Imatinib

(2017) Sebastian Eiden et al.   ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN

The Calcineurin Inhibitor Tacrolimus as a New Therapy in Severe Cherubism

(2015) Natacha Kadlub et al.   JOURNAL OF BONE AND MINERAL RESEARCH

CT Dose Optimization in Pediatric Radiology: A Multiyear Effort to Preserve the Benefits of Imaging While Reducing the Risks

(2015) Taylor J. Greenwood et al.   RADIOGRAPHICS

The Use of Bisphosphonates in Pediatrics

(2014) Giampiero I. Baroncelli et al.   Hormone Research in Paediatrics

SH3BP2 Cherubism Mutation Potentiates TNF-α-Induced Osteoclastogenesis via NFATc1 and TNF-α-Mediated Inflammatory Bone Loss

(2014) Tomoyuki Mukai et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effect of Denosumab on the Growing Skeleton in Osteogenesis Imperfecta

(2014) Heike Hoyer-Kuhn et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Enhanced TLR-MYD88 Signaling Stimulates Autoinflammation in SH3BP2 Cherubism Mice and Defines the Etiology of Cherubism

(2014) Teruhito Yoshitaka et al.   Cell Reports

Cherubism: panoramic and CT features in adults

(2013) M Redfors et al.   DENTOMAXILLOFACIAL RADIOLOGY

Anti-tumor necrosis factor treatment in cherubism — Clinical, radiological and histological findings in two children

(2012) M. Hero et al.   BONE

Denosumab treatment for fibrous dysplasia

(2012) Alison M Boyce et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Cherubism: best clinical practice

(2012) Maria E Papadaki et al.   Orphanet Journal of Rare Diseases

The role of SH3BP2 in the pathophysiology of cherubism

(2012) Ernst J Reichenberger et al.   Orphanet Journal of Rare Diseases

Increased expression of NFATc1 in giant cell lesions of the jaws, cherubism and brown tumor of hyperparathyroidism

(2011) ALESSANDRA PIRES DUARTE et al.   Oncology Letters

NFATc1 and TNFα expression in giant cell lesions of the jaws

(2010) Fabrício Rezende Amaral et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

SH3BP2 is an activator of NFAT activity and osteoclastogenesis

(2008) Steven A. Lietman et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism

(2008) Antonios O. Aliprantis et al.   JOURNAL OF CLINICAL INVESTIGATION